Welcome to Epistem
Epistem is an established Biotechnology Company with headquarters in Manchester UK, and facilities in the US. Founded on ground-breaking research in epithelial stem cell biology, Epistem has evolved into a dynamic and successful enterprise enabling advances in medicine through the provision of innovative services and pioneering products. For over ten years Epistem has been providing a personalised service to customers worldwide, from virtual start-ups to established biotechnology enterprises, global pharmaceutical and personal care companies.
Committed to providing reliable, innovative and transferable pre-clinical models and services to support decision making throughout the drug discovery and development pipeline.
Specialists in gene expression and DNA genotyping, providing GCLP accredited services to drug development and diagnostic programs.
A pioneering Point of Care/Need molecular diagnostic platform providing low cost, accurate, next generation genotyping and sequence analysis in 45-75 minutes depending on the assay.
Utilising Epistem's scientific heritage and expertise to identify key regulators of epithelial stem cell and develop novel therapeutics with implications in both oncology and regenerative medicine.